When Andrew Witty (photo [1]) takes over as CEO in May, he'll be running GlaxoSmithKline from London rather than from the U.S. HQ in Philadelphia as his predecessor Jean-Pierre Garnier did. No significant staff or resources will be relocated, and the company will continue to have a "dual headquarters" in both cities. Witty has been living in the UK as chief of the company's European operations. Report [2]
Links:
[1] http://www.fiercebiotech.com/story/glaxosmithkline-ceo-andrew-witty/2007-10-08
[2] http://business.timesonline.co.uk/tol/business/industry_sectors/health/article3174792.ece